Application of belinostat in preparation of medicine for preventing, relieving and/or treating multiple sclerosis
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
- Publication Date
- 2021-06-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the application of belistat in the preparation of drugs for preventing, alleviating and / or treating multiple sclerosis, and belongs to the technical field of medicine. Background technique
[0002] Multiple sclerosis (MS) is an autoimmune disease characterized by inflammatory demyelinating lesions of the central nervous system, which has the characteristics of high recurrence and disability. Clinical manifestations include paralysis, numbness, cramps, aphasia, and visual impairment. Epidemiological studies have shown that 50-300 people in every 100,000 people suffer from multiple sclerosis, and there are 2.3 million people in the world suffering from multiple sclerosis, mainly concentrated in European and American countries. The prevalence of multiple sclerosis increases with latitude, and the incidence of multiple sclerosis in women is twice that of men (Neurology.2014; 83(11):1022-1024). The etiology of multiple sclerosis i...